91AV原创

Tag - moderna

 
91AV原创
Search
 
October 27, 2026
 

Home Delivery
Subscribe for more access

MODERNA

Merck and Moderna said their personalized cancer vaccine helped prevent the return and spread of disease in a large trial involving more than 1,000 melanoma patients.
BUSINESS / Companies
Aug 20, 2026
Moderna and Merck’s breakthrough could usher in wave of cancer vaccines
The treatment involves pairing Merck’s immunotherapy drug with a customized mRNA vaccine that instructs the immune system to attack specific cancer cells.
Health workers prepare medicine for patients with Ebola in the Democratic Republic of the Congo on May 22.
WORLD / Science & Health
Jun 2, 2026
Moderna and other groups get $60 million to develop Ebola vaccine
Richard Hatchett, head of CEPI, said that it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months.
A new U.S. FDA policy requiring full placebo-controlled trials for updated vaccines, pushed by Commissioner Marty Makary (right) and U.S. HHS Secretary Robert F. Kennedy Jr. (center), is seen as a backdoor effort to sideline COVID-19 boosters and undermine broader vaccine development.
COMMENTARY / Japan
May 2, 2025
RFK Jr.’s new vaccine scrutiny is alarming
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly meet.
Japan Times
BUSINESS
Jul 6, 2023
Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
Japan Times
WORLD / Science & Health
Jun 6, 2023
Cancer vaccines poised to unlock ‘new treatment paradigm’ with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
Japan Times
COMMENTARY / World
Apr 21, 2023
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
WORLD / Science & Health
Apr 17, 2023
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer’s return.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
JAPAN
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizer’s omicron booster can be administered to people age 12 and over, while Moderna’s is limited to those 18 and above, the panel advised.
JAPAN / Science & Health / EXPLAINER
Aug 12, 2022
What we know about the new omicron vaccines
New vaccines developed for the COVID-19 omicron variant are scheduled to be available from mid-October in Japan, raising hopes that the population will soon be better protected.
JAPAN
Jun 3, 2022
Skin rash more common in women after Moderna shot, Japan study finds
Swelling, pain and/or itchiness of the arm that received the vaccine was also more common among people in their 30s through 60s.
Japan Times
COMMENTARY / World
Apr 11, 2022
We need better COVID-19 booster shots, not more of the same
There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.
Japan Times
BUSINESS / Companies
Mar 23, 2022
With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition
The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.
JAPAN
Feb 7, 2022
91AV原创 booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.
Japan Times
WORLD
Jan 27, 2022
Moderna starts trial for omicron-specific booster shot
The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.
Japan Times
WORLD / Science & Health
Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac’s and Sinopharm Group’s shots, which have been widely used in the developing world.
JAPAN / Explainer
Jan 6, 2022
The ins and outs of 91AV原创 COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what’s the rationale behind that strategy?
Japan Times
WORLD / Science & Health
Dec 20, 2021
Moderna says its booster dose appears protective against omicron
The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.
Japan Times
BUSINESS
Dec 14, 2021
Moderna to produce millions of mRNA vaccines in Australia
The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats.
Two Japanese climbers die on remote Himalayan peak in Nepal
Rescuers have recovered the bodies of two Japanese climbers missing for over a week on a remote Himalayan mountain.
Aging Japanese village turns to Peru in search of new residents
Guests from Peru's Belen district interact with a baby in Nanmoku village in Gunma Prefecture.
Budget-friendly restaurant chain Saizeriya succumbs to rising costs
A Tokyo branch of Saizeriya, a chain of family-style Italian restaurants
U.S. has for years asked Musk to alter Starlink service in Ukraine and Middle East, sources say
A Ukrainian soldier sets up a Starlink satellite internet system near the frontline in the Donetsk region, Ukraine, on Oct. 16
U.S. military bans Chinese-made BYD cars from key air base in Okinawa
An F-22 Raptor lands at Kadena Air Base in Kadena, Okinawa Prefecture on Oct. 9. The base is a crucial hub for U.S. military operations in the region.
A dramatic bear hunt in a midsize Japanese city could be a harbinger of what is to come
Zookeeper Tetsuo Iso at the site of frantic search for a wild bear in Utsunomiya on June 9. Iso, 65, was asked by the prefectural government to help capture the bear and it was his shot with a tranquilizer gun that put an end to the saga.
How this long-term resident avoids the annoying tourist label in Japan
Tourists enjoy themselves while crossing the famous Shibuya Crossing in Tokyo on Oct. 12.
What can Asia do to avoid crossing crucial climate tipping points?
Motorists drive through a road covered with smog from wildfires nearby in Ogan Ilir in Indonesia's South Sumatra province on Sept. 25.
Baku championships showcase rising standards in global sumo
Ryan Roddy (second from left back) is pictured with the Ireland sumo team at this month's World Sumo Championships in Baku, Azerbaijan.
91AV原创 permanent residency reform has a glaring blind spot
Japan's immigration reforms risk creating uncertainty by tying permanent residency more closely to language proficiency before clear assessment standards and supporting infrastructure are in place.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Famima Park Azabudai is a concept store by FamilyMart that combines convenience store staples with branded apparel, merchandise and a landscaped outdoor space.
Convenience stores, toilets and the allure of everyday Japan
By Elizabeth Beattie

SUSTAINABLE JAPAN

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER